Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Celcuity (CELC) Stock Price & Analysis

563 Followers

CELC Stock Chart & Stats

$64.32-$2.73(-4.07%)
At close: 4:00 PM EST
$60$70$80$90Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$64.27 - $67.95
52-Week Range
$53.54 - $151.02
Previous Close
$67.05
Volume
N/A
Average Volume (3M)
1.57M
Market Cap
$3.29B
Enterprise Value
$4.50B
Total Cash (Recent Filing)
$642.70M
Total Debt (Recent Filing)
$755.07M
Price to Earnings (P/E)
―
Beta
0.70
Next Earnings
Mar 25, 2027 (Est.)
EPS Estimate
-1.38
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Commercial Launch Access

Broad account adoption, payer coverage, NCCN inclusion, and provider-pathway placement give Revtopik a strong foundation for sustained commercialization. These access advantages can reduce adoption friction and support durable penetration in the targeted breast cancer treatment market over coming quarters.

Clinical Differentiation

The reported progression-free-survival advantage and favorable response outcomes provide evidence of meaningful clinical differentiation for gedatolisib-based regimens. If maintained in regulatory and broader commercial use, stronger efficacy can support physician preference, treatment persistence, and competitive positioning.

Funding Runway

Management’s projected funding runway through 2029 provides time to execute the commercial launch, advance late-stage trials, and pursue regulatory milestones without an immediately stated financing deadline. This supports operational continuity while the company works toward expanding product revenue.

Bears Say

Accelerating Losses

The company remains dependent on a newly launched product while reporting no revenue across the provided financial periods and sharply widening losses. A rising expense base creates pressure for future product adoption to scale quickly enough to offset development and commercialization spending.

Balance-Sheet Strain

Rapidly higher debt combined with negative equity materially reduces financial flexibility and downside protection. Even with substantial cash raised, this capital structure can increase refinancing and dilution exposure, while limiting the company’s ability to absorb setbacks or fund expansion solely through internal resources.

Regulatory Uncertainty

Expansion into the PIK3CA-mutant population still depends on regulatory interpretation, while overall-survival results remain pending and may be confounded by crossover. These unresolved outcomes could affect the eventual label, addressable market, clinical credibility, and commercial growth trajectory.

Celcuity News

CELC FAQ

What was Celcuity’s price range in the past 12 months?
Celcuity lowest stock price was $53.54 and its highest was $151.02 in the past 12 months.
What is Celcuity’s market cap?
Celcuity’s market cap is $3.29B.
When is Celcuity’s upcoming earnings report date?
Celcuity’s next earnings report is estimated for Mar 25, 2027 (not yet confirmed), which is in 132 days.
How were Celcuity’s earnings last quarter?
Celcuity released its earnings results on Nov 05, 2026. The company reported -$1.33 earnings per share for the quarter, beating the consensus estimate of -$1.512 by $0.182.
Is Celcuity overvalued?
According to Wall Street analysts Celcuity’s price is currently Undervalued.
Does Celcuity pay dividends?
Celcuity does not currently pay dividends.
What is Celcuity’s EPS estimate?
Celcuity’s EPS estimate is -1.38.
How many shares outstanding does Celcuity have?
Celcuity has 49,126,312 shares outstanding.
What happened to Celcuity’s price movement after its last earnings report?
Celcuity reported an EPS of -$1.33 in its last earnings report, beating expectations of -$1.512. Following the earnings report the stock price went up 4.294%.
Which hedge fund is a major shareholder of Celcuity?
Hedge funds hold Celcuity shares: the largest hedge-fund position in Celcuity is 70,144,143 shares, and hedge funds increased their holdings by 234.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology